Skip to content

Group News

Aspen closes EUR 1,26 billion syndicated loan facilities

Nov 8, 2022

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has closed a multi-currency, syndicated term loan and revolving credit facilities agreement. These facilities, totalling circa EUR 1,26 billion equivalent, were put in place to refinance Aspen’s 2018 syndicated loan facilities.  The facilities were structured across EUR, ZAR and AUD…

Read More >>

Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Aug 31, 2022

Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022. SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from continuing operations…

Read More >>

Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

Aug 31, 2022

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of India Pvt Ltd (“the Serum Institute”), the world’s largest vaccine producer, for…

Read More >>

Aspen partners with HappiMe to support Jiyana Secondary School

Aug 12, 2022

Johannesburg – Aspen Pharmacare, a leading global specialty and branded multinational pharmaceutical company, has donated 25 computers and 30 tablets to Jiyana Secondary School which produced one of the top performing students in Ekurhuleni in 2021. This donation forms part of the “Gender Equality Today for a Sustainable Tomorrow” program of the United Nations and…

Read More >>

Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

Jul 28, 2022

Durban – JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This declaration is the first since that announced…

Read More >>

Aspen hosts more than 800 Mandela Day activities over 12 years

Jul 18, 2022

“Our purpose, To improve the health and quality of life of patients is closely aligned to the ethos of Mandela Day. This has been clearly demonstrated through our endeavours to provide citizens across the continent with vaccines which are manufactured in South Africa for Africa.”   Durban – JSE Limited listed Aspen Pharmacare Holdings Limited…

Read More >>

Aspen donates life-saving surgical anaesthetics for about 240 000 Lebanese patients

Jun 20, 2022

Aspen’s donation of anaesthetics to Lebanese patients   Johannesburg, South Africa – Aspen Global Incorporated, a subsidiary of Pharmacare Limited, Africa’s largest pharmaceutical company, has donated a second supply of life-saving anaesthetics to Lebanon to facilitate surgical interventions to treat an additional 79 000 patients. This donation follows on Aspen’s donation of anaesthetics and oncology products…

Read More >>

Aspen presented with prestigious SAIC Business Award

Mar 25, 2022

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company was honoured at the 4th South African Investment Conference (“SAIC”) when it was presented with an award, by South African President Mr Cyril Ramaphosa, recognising Companies that Best Responded to the Challenges of the COVID Environment. The award acknowledges the role that…

Read More >>

Aspen announces R500 million investment at 4th SAIC

Mar 24, 2022

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha.   The announcement comes in the wake of more than R8 billion which Aspen has already invested in this world…

Read More >>

Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Mar 23, 2022

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further demonstrates Aspen’s ongoing commitment to saving lives and improving the quality of life of patients irrespective of their location or circumstances. Stavros Nicolaou Aspen Senior Executive…

Read More >>

MEDIA ENQUIRIES

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Scroll To Top